A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Condition: Chronic Kidney Disease, Secondary HyperparathyroidismInterventions: Drug: Cinacalcet HCl; Dietary Supplement: Standard of CareSponsor: AmgenRecruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2014 Category: Research Source Type: clinical trials
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Condition: Chronic Kidney Disease, Secondary HyperparathyroidismInterventions: Drug: Cinacalcet HCl; Dietary Supplement: Standard of CareSponsor: AmgenRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2014 Category: Research Source Type: clinical trials
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Condition: Chronic Kidney Disease, Secondary HyperparathyroidismInterventions: Drug: Cinacalcet HCl; Dietary Supplement: Standard of CareSponsor: AmgenNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2014 Category: Research Source Type: clinical trials
Assess Impact on Calcium Levels When Hemodialysis Subjects With SHPT Switch From Cinacalcet HCl to AMG 416
Condition: Hyperparathyroidism, SecondaryIntervention: Drug: AMG 416Sponsor: AmgenCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2013 Category: Research Source Type: clinical trials
Head-to-Head Study of AMG 416 and Cinacalcet
Condition: Secondary Hyperparathyroidism; Chronic Kidney DiseaseInterventions: Drug: AMG 416; Drug: cinacalcetSponsor: AmgenActive, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2013 Category: Research Source Type: clinical trials
Head-to-Head Study of AMG 416 and Cinacalcet
Condition: Secondary Hyperparathyroidism; Chronic Kidney DiseaseInterventions: Drug: AMG 416; Drug: cinacalcetSponsor: AmgenActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2013 Category: Research Source Type: clinical trials
Head-to-Head Study of AMG 416 and Cinacalcet
Condition: Secondary Hyperparathyroidism; Chronic Kidney DiseaseInterventions: Drug: AMG 416; Drug: cinacalcetSponsor: AmgenCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2013 Category: Research Source Type: clinical trials
